India Current Update

Jubilant Co. is set to sell a $139 million interest in a US corporation

<p><strong>NEW DELHI:</strong> For $139.4 million, Jubilant Pharma, a division of Jubilant Pharmova, will sell its whole 25.8% ownership in Sofie Biosciences, a US company. According to a statement from the firm, Singapore-based Jubilant Pharma contributed $25 million to Sofie in November 2020.</p>
<p><img decoding=”async” class=”alignnone wp-image-382453″ src=”” alt=” jubilant co is set to sell a 139 million interest in a us corporation 107274025 1″ width=”1017″ height=”572″ title=”Jubilant Co. is set to sell a $139 million interest in a US corporation 15″ srcset=” 400w,×220.png 390w,×84.png 150w” sizes=”(max-width: 1017px) 100vw, 1017px” /></p>
<p>Sofie is a company that develops and provides molecular medicines and diagnostics (theranostics). It possesses an advanced contract manufacturing services network, a radiopharmaceutical production and distribution network, and valuable therapeutic intellectual property.<br />
It and several private equity groups have recently finalized their merger deal.</p>

Related posts

ITR Trends: 15% Taxpayers Test New Tax System, 85% Choose Old With Deductions

Big earning opportunity! Tata’s company’s IPO coming after 19 years, SEBI approves

World Computer Literacy Day 2023: Top 5 Flipkart Offers Big Bachat Dhamaal Deals On The Greatest Laptops For Beginners

“Bharat is a declaration of independence,” Jaishankar says, emphasizing the need to develop a compelling “Bharat” story

Hacktivists from Bangladesh Target India With DDoS Attacks and Data Breach: Report

Sitharaman urges vigilance against threats as she promotes fintech resilience